Figure 2

Site-specific IMRT utilization. (A) shows IMRT utilization for head and neck cancer patients across cancer centers in Canada. IMRT was provided to "virtually all" patients versus "not used". (B) shows IMRT utilization for prostate cancer patients, and (C) shows IMRT utilization for breast cancer patients.